No Data
No Data
Replimune Group Is Maintained at Outperform by BMO Capital
H.C. Wainwright Maintains Replimune(REPL.US) With Buy Rating, Raises Target Price to $21
HC Wainwright & Co. Maintains Buy on Replimune Group, Raises Price Target to $21
Replimune Group Analyst Ratings
Express News | Replimune Group, Inc. : H.c. Wainwright Raises Target Price to $21 From $17
BMO Capital Maintains Replimune(REPL.US) With Buy Rating, Raises Target Price to $27